MUMBAI, India, April 20 -- Intellectual Property India has published a patent application (202617011442 A) filed by Ablynx Nv; and Sanofi, Zwijnaarde, Belgium, on Feb. 3, for 'improved fcrn antagonists for treatment of igg-related diseases and disorders.'
Inventor(s) include Van Bogaert, Tom; and Verhelst, Judith.
The application for the patent was published on April 17, under issue no. 16/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to FcRn antagonists which bind to the neonatal Fc receptor (FcRn) and interfere with binding of FcRn's natural ligands, the Fc region of IgG. In particular, the invention relates to FcRn antagonists comprising at least one first polypeptide speci...